Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$1.2 - $2.19 $175,435 - $320,169
-146,196 Reduced 30.28%
336,583 $447,000
Q1 2022

May 10, 2022

SELL
$2.83 - $8.69 $3.26 Million - $10 Million
-1,150,227 Reduced 70.44%
482,779 $1.95 Million
Q4 2021

Feb 14, 2022

SELL
$8.31 - $14.92 $6.22 Million - $11.2 Million
-748,264 Reduced 31.42%
1,633,006 $13.6 Million
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $21.8 Million - $31.6 Million
2,381,270 New
2,381,270 $27.6 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.